Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
iShares Nasdaq US Biotechnology UCITS ETF (BTEE.L)
USD9.45
-0.12 (-1.25%)
LSE USD IE Equity
NAV
USD 9.62
-1.77% vs NAV
as of 2026-07-13
AUM
USD 73.33M
TER
0.35%
Yield (TTM)
0.23%
Distribution
Distributing · Semi-Annual
52-week range
6.35 – 9.88
Holdings
259
Issuer
IShares
About this ETF
The iShares Nasdaq US Biotechnology UCITS ETF is structured to mirror the financial performance of a specific underlying index. This index comprises equities of biotechnology and pharmaceutical companies based in the US, which are primarily traded on the NASDAQ exchange.
ISIN
IE00BDZVHG35
Issuer
IShares
Domicile
IE
Inception
2018-03-04
Asset class
Equity
Price
Top 10 holdings
| VERTEX PHARMACEUTICALS INC VRTX | 7.85% |
| AMGEN INC AMGN | 7.81% |
| GILEAD SCIENCES INC GILD | 6.99% |
| REGENERON PHARMACEUTICALS INC REGN | 4.72% |
| ALNYLAM PHARMACEUTICALS INC ALNY | 2.75% |
| REVOLUTION MEDICINES INC RVMD | 2.74% |
| BIOGEN INC BIIB | 2.03% |
| ILLUMINA INC ILMN | 1.99% |
| MODERNA INC MRNA | 1.87% |
| ROIVANT SCIENCES LTD ROIV | 1.78% |
Sector mix
Price chart
USD9.45
-0.12 (-1.25%)
Loading historical data…
Returns
| 1 month | +9.12% |
| 3 months | +10.66% |
| 6 months | +13.72% |
| Year to date | +14.41% |
| 1 year | +46.51% |
| 3 years (ann.) | +16.28% |
| 5 years (ann.) | +5.44% |
| 10 years (ann.) | — |
Risk profile
| Volatility (1y, ann.) | 20.45% |
| Sharpe (1y) | 1.97 |
| Sharpe (3y) | 0.86 |
| Sortino (1y) | 3.68 |
| Max drawdown (1y) | -7.64% |
| Max drawdown (5y) | -38.56% |
| Max drawdown (full) | -38.56% |
| Beta vs S&P 500 (1y) | 0.54 |
| Correlation vs S&P 500 (1y) | 0.33 |
Technical outlook as of 2026-07-13
Day Score (bias 0-100, not a probability)
48
P(gain) 22 sessions — probability
53%
VaR 95% (daily)
-2.34%
CVaR 95% (daily)
-3.25%
GARCH vol forecast (22d)
1.43%
Market regime (Markov)
Lateral
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Top-10 concentration
40.5%
Effective holdings
38
Disclosed positions
259
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Loading map…
Cost vs. peers
BTEE.L
0.35%
Equity median
0.39%
Cheapest in class BKLC
0.00%
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Distributing share class Income is paid out to shareholders.
| Ex-date | Payment | Amount |
|---|---|---|
| 2026-06-18 | 2026-06-30 | USD 0.0110 |
| 2025-12-11 | 2025-12-24 | USD 0.0109 |
| 2025-06-12 | 2025-06-25 | USD 0.0200 |
| 2024-12-12 | 2024-12-27 | USD 0.0113 |
| 2024-06-13 | 2024-06-26 | USD 0.0175 |
| 2023-12-14 | 2023-12-29 | USD 0.0108 |
| 2023-06-15 | 2023-06-28 | USD 0.0142 |
| 2022-12-15 | 2022-12-30 | USD 0.0104 |
| 2022-06-16 | 2022-06-29 | USD 0.0165 |
| 2021-12-16 | 2021-12-31 | USD 0.0069 |
| 2021-06-17 | 2021-06-30 | USD 0.0104 |
| 2020-12-10 | 2020-12-23 | USD 0.0035 |
| 2020-06-11 | 2020-06-24 | USD 0.0084 |
| 2019-12-12 | 2019-12-27 | USD 0.0044 |
| 2019-06-13 | 2019-06-26 | USD 0.0030 |
| 2018-12-13 | 2018-12-28 | USD 0.0032 |
ESG profile
Derived from holdings
covers 92.9% of the portfolio by weight
(226 scored constituents)
Environmental
57.8
class avg 63.0
Social
61.4
class avg 62.3
Governance
62.6
class avg 64.9
Total ESG
60.6
class avg 63.4
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Vanguard Small-Cap ETF VB | 0.03% | 182.70B | 5.7% |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 2.6% |
| Vanguard Value ETF VTV | 0.03% | 245.00B | 1.7% |
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.7% |
| iShares Russell 1000 Growth ETF IWF | 0.18% | 128.11B | 1.1% |
